ACRX - AcelRx Pharmaceuticals GAAP EPS of -$0.08 beats by $0.20 revenue of $0.12M misses by $0.01M
2023-11-08 16:10:52 ET
More on AcelRx Pharmaceuticals
- AcelRx Pharmaceuticals, Inc. (ACRX) Q2 2023 Earnings Call Transcript
- AcelRx upgraded at HC Wainwright on likely authorization of anticoagulant
- Seeking Alpha’s Quant Rating on AcelRx Pharmaceuticals
- Historical earnings data for AcelRx Pharmaceuticals
- Financial information for AcelRx Pharmaceuticals
For further details see:
AcelRx Pharmaceuticals GAAP EPS of -$0.08 beats by $0.20, revenue of $0.12M misses by $0.01M